AdvaMedDx member companies produce innovative, high-quality in vitro diagnostic (IVD) tests that facilitate the early detection of disease and the guiding of appropriate treatments to improve the quality of patient care and public health. These include tests that are front-line tools in the fight against COVID-19, from diagnosing an active infection to identifying those who have been infected in the past even after the virus is no longer detectable, to supporting surveillance and vaccine development efforts